1. The effects of subdepressor infusion of prostacyclin (PG12, 5.3 pmol min-' kg-') on arterial pressure and aldosterone production induced by angiotensin I1 (ANG 11) were studied in conscious rabbits.
Introduction
In various experimental models, the prostaglandin E series [1, 2] and prostacyclin [3] have been reported to attenuate the vasoconstrictor responses to angiotensin I1 or noradrenaline. Since indomethacin or like-acting drugs have been shown to augment the pressor responses induced by these vasoactive hormones [4- bitory action on cyclo-oxygenase, it has been postulated that the endogenous prostaglandins (PG) may contribute to the modulation of blood pressure interacting with pressor substances at the vessel walls [3] . Recent study in man, however, suggests that the circulating PG12 is unlikely to have a physiological role in steady states, based on the observation that the plasina levels of 6-0x0-PGFl,, the stable hydrolysis product of PG12, is in the low range [7] , in agreement with the finding that the calculated PG12 production rate is extremely low [8] . Lack of evidence on plasma levels or production rate of PG12 in pathophysiological conditions, however, does not preclude a possibility that PG12 released into the circulation still serves to modulate vascular tone. Steroidogenic potency of PG was originally demonstrated with ox adrenals in vitro [9] . However, the role of PG12 in steroid production is controversial. We have recently shown that PG12 may be involved in the aldosterone response after ACTH administration in man [lo] . In order to investigate whether the circulating PG12 might have some role in the regulation of blood pressure, either directly or through its effect on aldosterone synthesis, we studied the effects of subdepressor PG12 infusion on aldosterone production and arterial pressure in conscious rabbits.
Materids and methods
Male New Zealand white rabbits weighing 2.5-3.5 kg were used. The ear artery was cannulated with a polyethylene tube under local anaesthesia. The tube was connected to a pressure transducer for a continuous recording of arterial pressure. The rabbits were divided into three groups of seven to nine in random order. In group 1, which acted as control to the other two groups, angiotensin I1 (ANG 11; Hypertensin, Ciba) (19 pmol min-' kg-') dissolved in sodium chloride solution (154 mmol/l) was infused for 30 min. In group 2 , indomethacin (8.4pmol/kg) dissolved in ethanol was given intramuscularly 60 min before the start of ANGII infusion. ANG I1 infusion was carried out in the same manner as in group 1. In group 3 , indomethacin pretreatment and ANG 11 infusion was done as in group 2, and PGIZ (Prostacyclin methyl ester, Ono Pharmaceutical, Osaka, Japan) (5.3 pmol min-' kg') was infused concomitantly with ANG 11, through a scalp vein needle in a marginal ear vein. PGIz was reconstituted in Tris buffer, pH 8.6, immediately before use. In each experiment, rabbits sat quietly in the resting box for a t least 20 min after ear artery cannulation. Blood samples (2 ml) were withdrawn three times from each rabbit from the arterial cannula during the experiment. Plasma renin activity (PRA) and plasma aldosterone were measured by radioimmunoassay as previously described [ll] . In a limited number of rabbits, plasma 6-0x0-PGF1, was determined by radioimmunoassay by the method reported by Salmon [12] . Briefly, 1.0 ml of plasma adjusted to pH 3.0 was extracted twice with 2.5 ml of acetic acid. After thin layer chromatography (Silicagel 60/Kieselguhr F 254, Merck) with the solvent system ethyl acetate/trimethylpentane/ acetic acid/water (1 1 : 5 : 2 : 10, by vol.), 6-0x0-PGFl, was extracted with ethyl acetate and measured by radioimmunoassay using antiserum made available by Seragen (Boston, U.S.A.). Statistical analysis was done by using analysis of covariance for comparison of the data between groups. For the analysis of the results within the same group, Student's t-test was used. Results are expressed as means k SEM.
Results

Effects of infusing incremental doses of PGI, on blood pressure and plasma immunoreactive 6-0x0-PGFI, levels
Results of intravenous infusion of PGIz at a dose range of Effects of indomethacin administration on mean blood pressure and plasma 6-0xo-fGF1, Indomethacin (8.4 pmol/kg intramuscularly) did not produce significant changes in MBP in conscious rabbits during the 90 min observation period (Table 1) . At 60min after indomethacin treatment, plasma 6-oxo-PGF1, decreased to 
Effects of indomethacin andlor PGI, on blood pressure response induced by ANG II
Baseline MBP in group 1 rabbits was 74.9 * 4.6 mmHg, which increased to 81.8 f 3.5 and 83.5 f 3.4 mmHg at 10 and 30 min respectively, after ANG I1 infusion at 19 pmol min-' kg-'. In group 2, baseline MBP was 74.2 f 4.9 mmHg; after 10 and 30 min of ANG I1 infusion, MBP increased to mmHg at 10 and 30 min after the start of ANG I1 infusion. There were no significant differences in basal MBP between the three groups. Blood pressure responses after ANG I1 infusion, however, were significantly larger in group 2 than in groups 1 or 2 (P< 0.05). In group 3, MBP changes were similar to those in group 1, demonstrating that the concomitant infusion of a subdepressor dose of PG12 significantly attenuated the augmented pressor response induced by ANG 11. The MBP responses after ANG I1 indicated by increment (changes from baseline) are shown in Fig. 2 .
Effects of indomethacin andfor PGIz on PRA and aldosterone responses induced by ANG 11 infusion
Basal PRA levels in groups 1, 2 and 3 were 5.5 f 1.0, 7.7 f 1.7 and 7.2 f 1.6 pmol of ANG I h-' ml-' respectively. After ANG I1 infusion for 30 min, PRA significantly decreased in all three groups ( Table 2 ). After ANG I1 infusion, plasma aldosterone increased from the basal concentration of 52.2 f 7.2 to 73.7 f 9 . 1 pmol/dl in group 1, in group 2 from 56.9 f 3.3 to 61.1 * 3.3 pmol/dl, and in group 3 from 53.3 * 2.5 to 66.1 f 3.1 pmol/ dl. Plasma aldosterone response was significantly lower in group 2, showing that 8.4 pmol of indomethacin/kg inhibits the plasma aldosterone stimulatory response induced by ANG 11. When the test was repeated while PGI2 was infused continuously (group 3), the reduced response to plasma aldosterone showed a tendency to be restored.
Discussion
Extensive studies have demonstrated the role of endogenous PG in the modulation of vascular tone. The E series of PG is particularly well known for its vasodilatory response in various animal species [ 1 , 2 , 131. Recent evidence indicates that the major PG produced in the vascular wall is prostacyclin [14] . Since PG12 has been shown to be 30-40 times more potent than PGE2 [15] for anti-platelet action and two to eight times for vasodilatation [16] , it may be postulated that PG12 is physiologically important for the blood pressure regulation. Furthermore, as the rate of inactivation of PG12 during passage through the lung was shown to be less than 15% [ 151, this raised the possibility that PGIz might be a circulating hormone [17] . This initial concept is now considered to be unlikely, in view of the finding that the basal plasma levels of 6-oxo-PGF1, measured by gas chromatography has been found to be less than 0.008 pmol/ml in man [7] . The estimated production rate of PG12 in man is also very low, which negates the putative role of PGI in the circulation [ 8 ] . In pathophysiological conditions, e.g. in hypoxia or in shock states with vasodilatation, TABLE 2 . Plasma renin activity (PRA) and plasma aldosterone before and after angiotensin I I ( 1 9 p m o l min-' kg-'J infusion in conscious rabbits Basal levels of plasma immunoreactive 6-0x0-PGF1, in four rabbits were also measured. PRA decreased after ANG I1 in groups 1 and 2. In group 1, basal plasma 6-0x0-PGF1, and the plasma aldosterone increment were significantly reduced. Means * SEM are shown: * P < 0.05 vs before ANG I1 infusion; ** P < 0.05 vs the other two groups. [25] . Plasma levels of 6-oxo-PGF1, in our experiment showed 16% decrease after indomethacin, which did not produce significant changes in blood pressure. Colina-Chouri and colleagues [26] reported that 42 pmol (1 5 mg) of indomethacin day-' kg-' (five times the dose used in the present experiment) raised mean blood pressure in rabbits, suggesting that larger doses of indomethacin than previously considered may be necessary to inhibit endogenous PG. Therefore it could be argued that endogenous PG may not be inhibited completely in our experiment. The blood pressure responsiveness to ANG 11, however, was significantly increased and was restored t o near control level after PG12 infusion. These results suggest that PG produced not only in the vessel wall but also in the circulation may serve in the modulation of blood pressure responses induced by ANG 11. Since we have not confirmed whether similar effects will also be observed after other types of cyclo-oxygenase inhibitors, we cannot completely exclude the possibility that PG-unrelated actions of indomethacin might be partly responsible for the present results [27, 28] . The mechanism(s) whereby PGIz in the circulation may influence the pressor action of ANGII is not apparent from the present study.
PG of the E series have been shown t o possess a steroidogenic property in ox adrenal [9] . Indomethacin causes a decrease in basal secretion of mineralocorticoids in man [29] , in support of the PG related adrenal steroidogenesis. We have previously reported that aldosterone production induced by ACTH in sodium depleted man is attenuated after indomethacin pretreatment, suggesting a role for endogenous PG, possibly PG12
[ l o ] . The role of endogenous PG in aldosterone production by the adrenal has been demonstrated in rat in vitro [24] and in man in vivo [6] , but the group of PG has not been specified. Our results demonstrate that PGIz may also be involved in aldosterone production after ANG I1 stimulation in the rabbit.
